Evidence map›Paper›PMID 33669003›Full record

ArticleInternational journal of molecular sciences2021

Development of

Thu Hang Lai, Susann Schröder, Magali Toussaint, Sladjana Dukić-Stefanović, Mathias Kranz, Friedrich-Alexander Ludwig, Steffen Fischer, Jörg Steinbach, Winnie Deuther-Conrad, Peter Brust and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Pathophysiological Role and Medicinal Chemistry of AMolecules (Basel, Switzerland) · 2022
    Review
  5. SThe Journal of organic chemistry · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Thu Hang LaiHelmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research site Leipzig, 04318 Leipzig, Germany.ORCID 0000-0001-8157-8979
Susann SchröderDepartment of Research and Development, ROTOP Pharmaka Ltd., Dresden 01328, Germany.ORCID 0000-0001-6440-1362
Magali ToussaintHelmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research site Leipzig, 04318 Leipzig, Germany.ORCID 0000-0002-1136-3857
Sladjana Dukić-StefanovićHelmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research site Leipzig, 04318 Leipzig, Germany.
Mathias KranzHelmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research site Leipzig, 04318 Leipzig, Germany.ORCID 0000-0002-5641-7396
Friedrich-Alexander LudwigHelmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research site Leipzig, 04318 Leipzig, Germany.ORCID 0000-0002-4358-5171
Steffen FischerHelmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research site Leipzig, 04318 Leipzig, Germany.
Jörg SteinbachHelmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research site Leipzig, 04318 Leipzig, Germany.
Winnie Deuther-ConradHelmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research site Leipzig, 04318 Leipzig, Germany.ORCID 0000-0003-3168-3062
Peter BrustHelmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research site Leipzig, 04318 Leipzig, Germany.ORCID 0000-0001-5555-7058
Rareş-Petru MoldovanHelmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research site Leipzig, 04318 Leipzig, Germany.ORCID 0000-0003-3119-7945
Helmholtz-Zentrum Dresden-Rossendorf · DEUniversity Hospital of North Norway · NO

Funding

European Regional Development Fund (ERDF) and Sächsische Aufbaubank (SAB) 100226753
6 · The paper itself

Abstract

The adenosine A

Indexed as

AdenosineAdenosine A2 Receptor AntagonistsAnimalsAutoradiographyBrainChromatography, High Pressure LiquidCricetinaeFluorine RadioisotopesHydrocarbons, FluorinatedMagnetic Resonance ImagingMiceMolecular Docking SimulationPositron-Emission TomographyRadiopharmaceuticalsReceptor, Adenosine A2AStructure-Activity RelationshipAdenosineAdenosine A2 Receptor AntagonistsFluorine RadioisotopesHydrocarbons, FluorinatedRadiopharmaceuticalsReceptor, Adenosine A2AA2A receptoradenosine receptorsfluorine-18positron emission tomographyvipadenant

Identifiers

PMID33669003
PMCPMC7956753
OpenAlexW3132974565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.